DIRECT
Path comparison
Similar words. Different systems.
A state-regulated service, clinical study, and educational source have different purposes, controls, entry points, and limits. They should never be collapsed into one promise of access.
QuestionState-regulated programClinical studyInformation source
Who governs it?State program agencies and license rulesStudy sponsor, investigators, IRB and applicable regulatorsThe publisher or public agency
What is the purpose?A regulated service defined by state lawAnswer a research question under a protocolProvide general information or safety guidance
Is it medical treatment?Do not assume; read the exact state frameworkResearch, not ordinary clinical careNo
How do you enter?Use the state program and verify a current licenseReview the live record and contact the listed study teamOpen and evaluate the source
What must be rechecked?License, rules, location, scope, current statusRecruitment, locations, criteria, consent, last updateAuthority, publication date, scope, and updates
Federal baseline
Research momentum does not erase current controls.
FDA’s current psychedelic-drug materials address drug development and regulatory activity. DEA identifies psilocybin as federally controlled. State programs, local enforcement decisions, clinical research, and FDA approval are legally distinct.
Open the authoritative sourcesReady to route?
Choose the location and purpose.
The pathfinder uses no health profile and makes no eligibility decision.
Open the pathfinder